News | November 05, 2021
UK authorises first Covid-19 pill
Applications remain under review by others including U.S. Food and Drug Administration and the European Medicines Agency
Applications remain under review by others including U.S. Food and Drug Administration and the European Medicines Agency
All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for WHO
The solution helps the pharma enterprises drive efficiencies, save costs, and increase productivity
The product is synthetically developed as compared to the current process of drawing the same from blood plasma and is backed by a granted global patent
Venus Remedies has reported consolidated financial results for the period ended September 30, 2021
The collaboration will combine Metagenomi’s next-generation CRISPR-based and other novel gene editing systems with Moderna’s mRNA and LNP technologies
Cortrophin gel is purified corticotropin (ACTH), an important treatment option for patients struggling with certain chronic autoimmune disorders. It acquired the NDA for cortrophin gel from Merck & Co. in 2016
Expertise in exosomes isolation and characterization will drive innovation in this field
Sputnik Light has been authorised in more than 15 countries with the registration process ongoing in a further 30 countries
This approval of shelf-life extension was based on the availability of additional stability data, which was submitted to CDSCO
Subscribe To Our Newsletter & Stay Updated
